HIVE Blockchain is still a buy, PI Financial says

HIVE Blockchain Technologies (HIVE Blockchain Stock Quote, Chart: TSXV:HIVE) has been hit hard by the downturn in cryptocurrency prices which has cut into its revenues over the last quarter.

But David Kwan of PI Financial remains bullish on the company, pointing out that even in the depressed environment HIVE has been able to produce positive gross margins on its crypto mining.

HIVE, which owns GPU- and ASIC-based mining facilities in Iceland and Sweden, generated revenue of $6.5 million for the quarter ended September 30, its fiscal Q2 2019, representing a 39 per cent drop from the previous quarter. The company’s Adjusted EBITDA for its Q2 was negative $0.8 million. (All figures in US dollars unless noted otherwise.)

Kwan calls the impact of the quarterly results a modest negative, saying that revenue and Adjusted EBITDA were below his $7.7 million and $1.5 million respective estimates. Its gross mining margin was down to 28.6 per cent from last quarter’s 60.4 per cent and below Kwan’s own estimate of 35.4 per cent.

“Operating and maintenance costs came in modestly below our forecast but not enough to offset the lower than expected revenue. Despite the ongoing weakness in cryptocurrency prices, HIVE is still able to generate positive gross mining margins,” says Kwan in an earnings update to clients on Friday.

Kwan points out that the company’s balance sheet remains strong, with $12.5 million in cash at the end of Q2 compared to $15.9 million at the end of the previous quarter.

The analyst has lowered his estimates, now calling for revenue of $33.8 million (was $39.4 million) in fiscal 2019 and $39.6 million (was $53.3 million) in fiscal 2020. On Adj. EBITDA, he now predicts $4.5 million (was $6.3 million) for fiscal 2019 and $6.6 million (was $13.8 million) in fiscal 2020.

Kwan is maintaining his “Buy” recommendation and “Speculative” risk rating with the reduced target price of C$0.40 (was C$0.70), representing a projected return of 29 per cent at the time of publication.

Tagged with: hive
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Elevate Service Group still a buy?

Beacon Securities analyst Donangelo Volpe says Elevate Service Group’s (Elevate Service Group Stock Quote, Chart, News, Analysts, Financials TSXV:SERV) first… [Read More]

9 hours ago

This analyst just raised his target on D-Wave to $40.00

Roth Capital Partners analyst Suji Desilva says D-Wave Quantum’s (D-Wave Quantum Stock Quote, Chart, News, Analysts, Financials NYSE:QBTS) first investor… [Read More]

11 hours ago

Firefly Aerospace has a “significant” opportunity, this analyst says

Roth Capital Partners analyst Suji Desilva says Firefly Aerospace’s (Firefly Aerospace Stock Quote, Chart, News, Analysts, Financials NASDAQ:FLY) latest equity… [Read More]

11 hours ago

Stifel raises price target on WELL Health Technologies

Stifel analyst Justin Keywood says WELL Health Technologies’ (WELL Health Technologies Stock Quote, Chart, News, Analysts, Financials TSX:WELL) $160-million imaging-clinic… [Read More]

12 hours ago

Celestica is a core AI play, this investor says

Velocity Investment Partners fund manager Brianne Gardner says Celestica (Celestica Stock Quote, Chart, News, Analysts, Financials TSX:CLS) remains a holding… [Read More]

1 day ago

This analyst just raised his price target on USA Rare Earth

Roth Capital Partners analyst Suji Desilva says USA Rare Earth (USA Rare Earth  Stock Quote, Chart, News, Analysts, Financials NASDAQ:USAR)… [Read More]

1 day ago